We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+14.4%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$2.47B
AUM Growth
-$383M
Cap. Flow
-$659M
Cap. Flow %
-26.68%
Top 10 Hldgs %
20.57%
Holding
503
New
157
Increased
65
Reduced
85
Closed
179

Top Buys

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$69.6M
2
LOW icon
Lowe's Companies
LOW
+$47.6M
3
NSC icon
Norfolk Southern
NSC
+$37.4M
4
HAS icon
Hasbro
HAS
+$36.3M
5
DLTR icon
Dollar Tree
DLTR
+$34.4M

Top Sells

Rank Stock Value
1
SN icon
SharkNinja
SN
+$69.8M
2
MSFT icon
Microsoft
MSFT
+$64.6M
3
DIS icon
Walt Disney
DIS
+$62.7M
4
KVUE icon
Kenvue
KVUE
+$48.3M
5
TGT icon
Target
TGT
+$44.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.49%
2 Technology 10.33%
3 Industrials 10.03%
4 Healthcare 8.86%
5 Communication Services 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PII icon
151
PUT
Polaris
PII
$3.82B
$3.39M 0.14%
+35,800
New +$3.28M
VRTX icon
152
CALL
Vertex Pharmaceuticals
VRTX
$121B
$3.34M 0.14%
+8,200
New +$3.03M
XLI icon
153
State Street Industrial Select Sector SPDR ETF
XLI
$32.8B
$3.3M 0.13%
28,942
-30,783
-52% -$3.23M
CPNG icon
154
PUT
Coupang
CPNG
$29.3B
$3.16M 0.13%
+195,000
New +$3.22M
DAKT icon
155
Daktronics
DAKT
$955M
$3.14M 0.13%
+369,700
New +$3.53M
BMRN icon
156
CALL
BioMarin Pharmaceuticals
BMRN
$11.6B
$3.13M 0.13%
+32,500
New +$2.88M
CARG icon
157
CarGurus
CARG
$3.27B
$3.12M 0.13%
129,221
+15,914
+14% +$320K
XENE icon
158
CALL
Xenon Pharmaceuticals
XENE
$6.06B
$3.11M 0.13%
+67,500
New +$2.38M
ANF icon
159
CALL
Abercrombie & Fitch
ANF
$4.42B
$3.09M 0.12%
+35,000
New +$2.49M
PPH icon
160
PUT
VanEck Pharmaceutical ETF
PPH
$959M
$3.05M 0.12%
+37,500
New +$2.94M
LLY icon
161
PUT
Eli Lilly
LLY
$1.02T
$3.03M 0.12%
+5,200
New +$3.04M
SLNO
162
DELISTED
Soleno Therapeutics
SLNO
$2.95M 0.12%
73,252
+7,252
+11% +$206K
CBAY
163
PUT
DELISTED
Cymabay Therapeutics
CBAY
$2.94M 0.12%
124,500
-10,500
-8% -$187K
RIVN icon
164
PUT
Rivian
RIVN
$22B
$2.93M 0.12%
125,000
-175,000
-58% -$3.29M
ANIP icon
165
ANI Pharmaceuticals
ANIP
$1.8B
$2.82M 0.11%
+51,119
New +$2.81M
DXCM icon
166
PUT
DexCom
DXCM
$31.5B
$2.79M 0.11%
+22,500
New +$2.3M
CWH icon
167
CALL
Camping World
CWH
$639M
$2.73M 0.11%
+104,100
New +$2.18M
ABBV icon
168
PUT
AbbVie
ABBV
$443B
$2.71M 0.11%
+17,500
New +$2.55M
NCLH icon
169
PUT
Norwegian Cruise Line
NCLH
$8.51B
$2.71M 0.11%
135,000
+96,700
+252% +$1.55M
M icon
170
CALL
Macy's
M
$6.53B
$2.64M 0.11%
+131,300
New +$1.9M
AMLP icon
171
Alerian MLP ETF
AMLP
$13B
$2.63M 0.11%
61,890
-767
-1% -$32.5K
PFE icon
172
PUT
Pfizer
PFE
$143B
$2.52M 0.1%
+87,500
New +$2.65M
MA icon
173
Mastercard
MA
$502B
$2.52M 0.1%
+5,905
New +$2.37M
GPN icon
174
Global Payments
GPN
$23B
$2.42M 0.1%
+19,048
New +$2.21M
WOOF icon
175
PUT
Petco
WOOF
$797M
$2.39M 0.1%
757,500
+1,500
+0.2% +$5.18K
5 6
7
8 9

Similar funds

CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return
PWP
Perfromance Wealth Partners Hinsdale, Illinois $3.45B AUM 29.14% 1-Year Est. Return
RBA
Richard Bernstein Advisors New York $3.45B AUM 16.24% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $3.44B AUM 9.15% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
LNC
Lincoln National Corp Radnor, Pennsylvania $3.45B AUM 12.55% 1-Year Est. Return
DAM
Davis Asset Management Sausalito, California $3.46B AUM 9.77% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

J. Goldman & Co's Q4 2023 Portfolio in Review

As of Q4 2023, J. Goldman & Co held 503 positions worth $2.47B, down 13% from $2.85B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

J. Goldman & Co withdrew a net $659M in Q4 2023, closing 179 positions and reducing 85 holdings. Its most notable exit was Kenvue, an estimated $48.3M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

Against the trend, J. Goldman & Co opened a new position in Lowe's Companies worth $52.2M.

  • J. Goldman & Co's largest Q4 2023 buy was Lowe's Companies: 234,677 shares worth $52.2M.
  • J. Goldman & Co added most to PayPal in Q4 2023, an estimated $69.6M increase.
  • J. Goldman & Co's biggest Q4 2023 reduction was SharkNinja, cutting an estimated $69.8M.
  • J. Goldman & Co fully exited Kenvue in Q4 2023, selling an estimated $48.3M.
  • J. Goldman & Co's ten largest holdings make up 21% of its $2.47B portfolio in Q4 2023.
  • J. Goldman & Co opened 157 new positions and closed 179 in Q4 2023.
  • J. Goldman & Co's portfolio value fell 13% quarter-over-quarter to $2.47B.

Based on J. Goldman & Co's 13F filing for Q4 2023, filed 14 Feb 2024.